Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Tempus AI Plans Convertible Notes to Cut Interest Costs
Tempus AI, a technology company leading the adoption of AI to advance precision medicine and patient care, today announced its intent to offer, subject to market conditions and other factors, $400 million aggregate principal amount of Convertible Senior Notes due in 2030 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Tempus also intends to grant the initial purchasers of the Notes an over-allotment option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $60 million aggregate principal amount of Notes.
OS Therapies Shares Positive 1-year Survival And Safety Data For Ost-her2 At Osteosarcoma Conference
OS Therapies, a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, announced positive 1-year event free survival, overall survival and safety clinical trial data updates from the 40 patient treatment arm of its Phase 2b clinical trial of immunotherapy candidate OST-HER2 in the prevention or delay of recurrence in fully resected, lung metastatic osteosarcoma.
Endo Tools Therapeutics partners with Fujifilm ME to expand obesity treatment access
Endo Tools Therapeutics, a company developing and marketing advanced endoscopic medical devices, and Fujifilm Middle East FZE, a subsidiary of FUJIFILM Holdings Corporation, announce their strategic partnership, to enable patients living with obesity in the Middle East and Africa to access a novel endoscopic treatment through ETT’s endomina platform.
Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals and Pharmaceuticals from KKR
Torrent Pharmaceuticals Limited and global investment firm KKR announced that Torrent has entered into definitive agreements to acquire controlling stake in J. B. Chemicals and Pharmaceuticals from KKR at an Equity Valuation of INR 25,689 crores, followed by a merger of the two entities. The transaction marks a significant step in Torrent’s ambition to create a future-ready, diversified healthcare platform combining a deep chronic segment heritage with emerging international CDMO capabilities.
HealthpointCapital Acquires ImmersiveTouch, a Leading Extended Reality Surgical Platform
ImmersiveTouch’s ImmersiveView platform is a patented, proprietary Virtual Reality (VR) and Augmented Reality (AR) software solution for surgical planning, navigation and patient-customized surgical guides. Currently focused on facial and thoracic trauma surgery for Craniomaxillofacial, ENT, Plastic, Neuro and Trauma surgeons, the platform features a range of versatile capabilities to create interactive, 3D, real-time surgical plans optimized for efficiency.
To share your insights, please write to us at sudipto@intentamplify.com
